Topical cyclosporine for atopic keratoconjunctivitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topical Cyclosporine for Atopic Keratoconjunctivitis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436485/all/Topical_cyclosporine_for_atopic_keratoconjunctivitis.
Topical cyclosporine for atopic keratoconjunctivitis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436485/all/Topical_cyclosporine_for_atopic_keratoconjunctivitis. Accessed July 20, 2025.
Topical cyclosporine for atopic keratoconjunctivitis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436485/all/Topical_cyclosporine_for_atopic_keratoconjunctivitis
Topical Cyclosporine for Atopic Keratoconjunctivitis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 July 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436485/all/Topical_cyclosporine_for_atopic_keratoconjunctivitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topical cyclosporine for atopic keratoconjunctivitis
ID - 436485
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436485/all/Topical_cyclosporine_for_atopic_keratoconjunctivitis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -